A detailed history of Keudell transactions in Amgen Inc stock. As of the latest transaction made, Keudell holds 4,355 shares of AMGN stock, worth $1.44 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
4,355
Previous 4,247 2.54%
Holding current value
$1.44 Million
Previous $1.21 Million 12.68%
% of portfolio
0.4%
Previous 0.37%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$262.75 - $319.31 $28,377 - $34,485
108 Added 2.54%
4,355 $1.36 Million
Q1 2024

May 07, 2024

SELL
$268.87 - $324.56 $28,769 - $34,727
-107 Reduced 2.46%
4,247 $1.21 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $136,288 - $153,749
-533 Reduced 10.91%
4,354 $1.25 Million
Q3 2023

Oct 18, 2023

BUY
$218.65 - $271.46 $42,199 - $52,391
193 Added 4.11%
4,887 $1.31 Million
Q2 2023

Jul 20, 2023

BUY
$214.27 - $253.37 $255,838 - $302,523
1,194 Added 34.11%
4,694 $1.04 Million
Q1 2023

Apr 18, 2023

BUY
$225.79 - $275.2 $69,994 - $85,312
310 Added 9.72%
3,500 $846,000
Q4 2022

Jan 20, 2023

SELL
$229.03 - $291.01 $186,201 - $236,591
-813 Reduced 20.31%
3,190 $0
Q3 2022

Oct 12, 2022

BUY
$224.46 - $253.15 $95,844 - $108,095
427 Added 11.94%
4,003 $902,000
Q2 2022

Jul 18, 2022

BUY
$230.71 - $256.74 $9,459 - $10,526
41 Added 1.16%
3,576 $870,000
Q1 2022

Apr 18, 2022

SELL
$219.27 - $242.57 $14,910 - $16,494
-68 Reduced 1.89%
3,535 $855,000
Q4 2021

Feb 08, 2022

BUY
$198.88 - $227.6 $103,019 - $117,896
518 Added 16.79%
3,603 $811,000
Q3 2021

Oct 20, 2021

BUY
$212.27 - $248.7 $72,808 - $85,304
343 Added 12.51%
3,085 $656,000
Q2 2021

Jul 13, 2021

BUY
$233.58 - $259.14 $34,803 - $38,611
149 Added 5.75%
2,742 $668,000
Q1 2021

Apr 13, 2021

BUY
$221.91 - $258.6 $35,727 - $41,634
161 Added 6.62%
2,593 $645,000
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $8,655 - $10,306
40 Added 1.67%
2,432 $559,000
Q3 2020

Oct 20, 2020

BUY
$234.65 - $260.95 $6,335 - $7,045
27 Added 1.14%
2,392 $608,000
Q2 2020

Jul 14, 2020

BUY
$197.81 - $242.74 $17,209 - $21,118
87 Added 3.82%
2,365 $558,000
Q1 2020

Apr 20, 2020

BUY
$182.24 - $241.7 $43,008 - $57,041
236 Added 11.56%
2,278 $462,000
Q4 2019

Jan 29, 2020

BUY
$189.21 - $243.2 $56,195 - $72,230
297 Added 17.02%
2,042 $492,000
Q2 2019

Aug 23, 2019

BUY
$166.7 - $195.41 $290,891 - $340,990
1,745 New
1,745 $320,000
Q2 2019

Aug 21, 2019

SELL
$166.7 - $195.41 $324,231 - $380,072
-1,945 Closed
0 $0
Q1 2019

Aug 21, 2019

BUY
$180.87 - $203.88 $351,792 - $396,546
1,945 New
1,945 $370,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $177B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Keudell Portfolio

Follow Keudell and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.